Search results for "ARTERIAL"

showing 10 items of 714 documents

ASSOCIATION OF SERUM URIC ACID WITH AORTIC STIFFNESS IN UNTREATED HYPERTENSIVE SUBJECTS.

2013

INTRODUCTION: Recent studies have reported an association between serum uric acid (SUA) and reduced arterial elasticity. However, in these studies arterial elastic properties have been assessed chiefly by measuring brachial-ankle pulse wave velocity (PWV) or peripheral PWV and only sometimes by using aortic PWV, that is considered the gold standard for measuring arterial stiffness. Moreover, the studies exploring the influence of SUA on aortic distensibility in subjects with arterial hypertension yielded conflicting results. AIM: The purpose of our study was to evaluate the relationships between SUA and aortic stiffness in a group of essential hypertensive patients. METHODS: We enrolled 222…

SERUM URIC ACIDAORTIC STIFFNESSARTERIAL HYPERTENSION
researchProduct

Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice.

2015

Hepatocellular carcinoma is a challenging malignancy of global importance. It is the sixth most common solid malignancy and the third leading cause of cancer-related death, worldwide. Curative treatments at early stages include liver transplantation, resection and percutaneous ablation, while transarterial chemoembolization can improve survival in patients with intermediate tumor stage. Patients with mild, related symptoms and/or macrovascular invasion or extrahepatic spread are classified under the advanced stage. The standard of care in this group is sorafenib, an inhibitor of Raf kinase and vascular endothelial growth factor receptor, whose effectiveness has been proven by 2 recent rando…

SHARPOncologyHepatocellular carcinomamedicine.medical_treatmentOLTLiver transplantationGastroenterologyLiver cirrhosilaw.inventionAntineoplastic AgentRandomized controlled triallawPractice Patterns Physicians'Randomized Controlled Trials as TopicNexavarMedicine (all)Liver NeoplasmsGastroenterologyGeneral MedicineSorafenibLocoregional therapiePercutaneous ethanol injectionLiver NeoplasmRaf kinaseHepatocellular carcinomaLiver cancerLiver cancerHumanmedicine.drugSorafenibNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsMalignancyTransarterial chemoembolizationInternal medicinemedicineCarcinomaChemotherapyHumansChemoembolization Therapeuticbusiness.industryPhenylurea CompoundsRadiofrequency ablationResectionmedicine.diseaseBCLCPercutaneous ethanol injectionbusinessDigestive diseases (Basel, Switzerland)
researchProduct

Input for baroreflex analysis: which blood pressure signal should be used?

2022

The baroreflex (BR) is an important physiological regulatory mechanism which reacts to blood pressure perturbations with reflex changes of target variables such as the heart period (electrocardiogram derived RR interval) or the peripheral vascular resistance (PVR). Evaluation of cardiac chronotropic (RR as a target variable) and vascular resistance (target PVR) BR arms was in previous studies mainly based on the use of the spontaneous variability of the systolic or diastolic blood pressure (SBP, DBP), respectively, as the input signals. The use of other blood pressure measures such as the mean blood pressure (MBP) as an input signal for BR analysis is still under investigation. Making the a…

Settore ING-INF/06 - Bioingegneria Elettronica E InformaticaArterial baroreflex blood pressure cardiovascular variability spectral analysis transfer function head-up tilt mental arithmetic task muscle sympathetic nerve activity
researchProduct

4. Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine.

2016

In the last decades, many factors thought to be associated with the atherosclerotic process and cardiovascular events have been studied, and some of these have been shown to correlate with clinical outcome, such as arterial stiffness, endothelial dysfunction and immunoinflammatory markers. Arterial stiffness is an important surrogate marker that describes the capability of an artery to expand and contract in response to pressure changes. It can be assessed with different techniques, such as the evaluation of PWV and AIx. It is related to central systolic pressure and it is an independent predictor of cardiovascular morbidity and mortality in hypertensive patients, type 2 diabetes, end-stage…

Settore MED/09 - Medicina Internasurrogate arterial stiffness endothelial dysfunction
researchProduct

RELATIONSHIP BETWEEN URIC ACID AND RENAL DAMAGE IN HYPERTENSIVE PATIENTS: WHICH ROLE FOR RENAL HAEMODYNAMICS

2016

Settore MED/14 - NefrologiaSettore MED/09 - Medicina InternaURIC ACIDRENAL FUNCTIONARTERIAL HYPERTENSION
researchProduct

BILATERAL RENAL ARTERY STENOSIS IN A HYPERTENSIVE LUPUS PATIENT WITHOUT RENAL DYSFUNCTION: A CASE REPORT

2014

Systemic lupus erythematosus (SLE) is associated with a high prevalence of atherosclero-sis and an enhanced cardiovascular mortality. In adult subjects, several studies have shown the coexistence of SLE and renal artery stenosis, most of them with unilateral in-volvement or with renal dysfunction. We observed a 62-year-old man with SLE and a 10-year history of moderate-to-severe hy-pertension who was admitted to our hospital because of uncontrolled blood pressure val-ues (152/95 mmHg), despite drug therapy. No signs of renal impairment were evident. After an initial physical examination, which presented a periumbilical bruit, a renal ultra-sound was performed with evidence of bilateral rena…

Settore MED/14 - Nefrologiaarterial hypertensionSettore MED/16 - ReumatologiaatherosclerosiSettore MED/09 - Medicina InternaSystemic lupus erythematosuSettore MED/11 - Malattie Dell'Apparato Cardiovascolarerenal artery stenosi
researchProduct

[OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS

2016

OBJECTIVE: Left ventricular hypertrophy is common in hypertensive patients. In these subjects increased oxidative stress has been observed. Our aim was to evaluate the association of biomarkers of both oxidative stress and inflammation with markers of cardiovascular damage in a large group of hypertensives with different stages of renal function. DESIGN AND METHOD: In 517 hypertensives we analyzed left ventricular mass indexed for body surface area, and we assayed plasma levels of 8-isoprostaglandin F2alpha and high sensitivity C reactive protein. RESULTS: Multivariate analysis carried out considering left ventricular mass as dependent variable, and including 8-isoprostaglandin F2alpha, hig…

Settore MED/14 - Nefrologiamedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industrymedicine.disease_causeLEFT VENTRICULAR HYPERTROPHY - ARTERIAL HYPERTENSION - OXIDATIVE STRESSSettore MED/11 - Malattie Dell'Apparato CardiovascolareCardiac hypertrophyInternal medicineInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicinebusinessOxidative stressJournal of Hypertension
researchProduct

Cardiovascular effects of occupational exposure to urban airborne pollution on a group of newsagents in the city of Palermo

2014

Aims: To verify the possible correlation between exposure to airborne particulate matter the average size less than 10 μm (PM 10) of a group of newsagents working in kiosks in Palermo and evidence of carotid intimal thickening. Materials and methods: data were collected relating to environmental monitoring of airborne pollutants. We have selected a sample of newsagents, who were submitted to some clinical investigations, including the carotid echo-color doppler examination. Results: The results show no correlation between the location of the kiosks, and the presence of intimal thickening. Conclusion: Exposition to urban pollutants in Palermo is likely homogenous in the different areas and c…

Settore MED/44 - Medicina Del LavoroAir pollution arterial intimal thickening particulate air matter PM10 cardiovascular diseases.
researchProduct

Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hyperten…

2012

This article is aimed at addressing the current state of the art in epidemiology, pathophysiology, diagnostic procedures and treatment options for appropriate management of obstructive sleep apnea (OSA) in cardiovascular (particularly hypertensive) patients, as well as for the management of cardiovascular diseases (particularly arterial hypertension) in OSA patients. The present document is the result of the work done by a panel of experts participating in the European Union COST (COoperation in Scientific and Technological research) ACTION B26 on OSA, with the endorsement of the European Respiratory Society (ERS) and the European Society of Hypertension (ESH). These recommendations are par…

Societies Scientificmedicine.medical_specialtyPhysiologyArterial hypertension continuous positive airway pressure treatment guidelines hypertension treatment obstructive sleep apnoeaComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioCheyne–Stokes respirationEpidemiologyarterial hypertension continuous positive airway pressure treatment guidelines hypertension treatment obstructive sleep apneaInternal MedicinemedicineHumansmedia_common.cataloged_instanceEuropean unionIntensive care medicinemedia_commonSleep Apnea Obstructivebusiness.industrySleep apneaMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareComorbidityEuropeSurvival RateObstructive sleep apneaBlood pressureHypertensionPractice Guidelines as TopicPosition papermedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Future perspectives in hepatocellular carcinoma.

2010

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide. Due to late diagnosis and advanced underlying liver cirrhosis, only limited treatment options with marginal clinical benefits have been available in up to 70% of patients. However, major progress has been achieved with regard to surveillance, early diagnosis, and multimodal treatment approaches during the last years leading to an improvement in prognosis. Particularly, the increasing knowledge of molecular hepatocarcinogenesis today provides the opportunity for targeted therapy. The multikinase inhibitor sorafenib has broadened the therapeutic horizon for patients with advanced disease and is current…

SorafenibOncologyAblation Techniquesmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationGastroenterologyTargeted therapyInternal medicinemedicineAdjuvant therapyCombined Modality TherapyHumansChemoembolization TherapeuticPrecision MedicineTranscatheter arterial chemoembolizationProtein Kinase InhibitorsHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseaseCombined Modality TherapyFibrosisLiver TransplantationHepatocellular carcinomaPersonalized medicinebusinessmedicine.drugForecastingDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct